Budget Amount *help |
¥162,630,000 (Direct Cost: ¥125,100,000、Indirect Cost: ¥37,530,000)
Fiscal Year 2018: ¥30,290,000 (Direct Cost: ¥23,300,000、Indirect Cost: ¥6,990,000)
Fiscal Year 2017: ¥30,290,000 (Direct Cost: ¥23,300,000、Indirect Cost: ¥6,990,000)
Fiscal Year 2016: ¥30,420,000 (Direct Cost: ¥23,400,000、Indirect Cost: ¥7,020,000)
Fiscal Year 2015: ¥30,290,000 (Direct Cost: ¥23,300,000、Indirect Cost: ¥6,990,000)
Fiscal Year 2014: ¥41,340,000 (Direct Cost: ¥31,800,000、Indirect Cost: ¥9,540,000)
|
Outline of Final Research Achievements |
We identified transcriptome and cell biological differences among hematopoietic stem cell (HSC) aging and cellular senescence. We also found that megakaryocyte, a differentiated cell originated from HSC, was a niche cell for HSCs. Reanalysis of p38MAPK cascade, a signaling pathway that had been clarified as an inducer for HSC aging, revealed that it also protected HSCs from acute stresses. Finally, we developed a method to maintain quiescent HSCs from aging ex vivo.
|